🤝Un gran agradecimiento al equipo de @geteccu por una colaboración productiva 🎯 en la RPQ de #Crohn
⭐️#PatientExperience @ACCU_Espana
Ahora es el momento de
#PostConvo
10/#MondayNightIBD #GITwitter
🔴#PostConvo #IBDPoll 4⃣
🔴According to the 2022 proposed new Expert Consensus for refractory #Crohn #PerianalFistula #PF (@LancetGastroHep http://bit.ly/3l6UgIb) despite ostomy requiring proctectomy is considered which class?
9/#MondayNightIBD #Crohns #PerianalFistula
🔴#PostConvo #IBDPoll 3⃣
#CME🔗http://bit.ly/CPF-MNIBD2
🔴42yo F w refractory #CPF #Fistula asks about possibility of receiving Mesenchymal #StemCell (MSC therapy) on a clinical trial.
What do u tell them about the process?
MSCs are:
8/#MNIBDWebinar #PerianalFistula
🔴#PostConvo #IBDPoll 2️⃣
🔴25yo M w recent dx of #Crohns presents w📈perianal pain
Pelvic MRI: perianal abscess + complex #fistula
EUA: abscess drained + seton placed
Pt asks what to expect RE: efficacy of current Med/Surg #CPF therapies?
7/#MondayNightIBD #GITwitter #MedTwitter #CPF
🔴#PostConvo #IBDPoll 1️⃣
#CME🔗http://bit.ly/CPF-MNIBD2
🔴➕Addition of which of the following to an anti-TNF agent is associated w/ a higher rate of #Crohns #PerianalFistula #CPF healing vs anti-TNF agent alone?
12/#ICYMI #MondayNightIBD
💡 Focus: #MNIBDWebinar #pediatric patients w/ #ShortBowelSyndrome
---
RT @MondayNightIBD
⌛️#GITwitter #PedsGI - the wait is over!
🎆 Join @valcohranmd & @DCharabaty
📽️#MNIBDWebinar🎞#ShortBowelSyndrome Consult w the Expert
#CME👉 🔗http://bit.ly/sbs-consult-1-cmeinfo
👇#PostConvo #IBDPolls
Supported by an educational grant from @TakedaPharma https://twitter.com/i/broadcasts/1PlKQpRZXDDxE
https://twitter.com/MondayNightIBD/status/1569446068492062720
8/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE
🔴 #PostConvo #IBDPoll 4⃣
🏅 #CME ➡️ http://bit.ly/SBS-Consult2
🔴Which of the following is considered to be a potentially disease-modifying treatment for pts w/ #ShortBowelSyndrome?
7/#MondayNightIBD
🔴#PostConvo #IBDPoll 3⃣
🏅#CME ➡️ http://bit.ly/SBS-Consult2
🔴#MedPeds pt w #ShortBowelSyndrome is being evaluated as an inpatient consult, following a recent emergency resection, w 55 cm of small bowel remaining.
Which is an appropriate initial mgmt strategy?
6/#MondayNightIBD #PedsGI
🔴#PostConvo #IBDPoll 2⃣
🏅#CME ➡️ http://bit.ly/SBS-Consult2
🔴Young adult pt w/ SBS is experiencing significant diarrhea (≥20 BM/day) despite tx w 8 mg/day loperamide.
Appropriate mgmt includes _____
5/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE
🔴#PostConvo #IBDPoll 1️⃣
🏅 #CME ➡️ http://bit.ly/SBS-Consult2
🔴The GLP-2 analog teduglutide was shown in clinical studies to be associated w/ which of the following outcomes?
8/#MondayNightIBD #UEGWeek
👇#PostConvo #IBDPoll 4⃣
🟢The U-ACHIEVE Maintenance study, looked @ pts w UC who responded to induction tx w upadacitinib @ 8wks
Which tx group led to greater clinical remission per adapted Mayo score at wk 52 compared to PBO?
6/#MondayNightIBD #UEGWeek
👇#PostConvo #IBDPoll 2⃣
🟢Which drug combo were given in the Ph2a VEGA study to show the potential of dual inhibition of IL-23 & TNFα to more effectively induce CR & remission in pts w mod-sev UC?
7/#MondayNightIBD #UEGWeek
👇#PostConvo #IBDPoll 3⃣
🟢Which of the following PRO questionnaires assesses pt fatigue using a 13-item tool & 5-point scale, where a ⬆️higher score indicates a better pt outcome?
5/#MondayNightIBD #UEGWeek
👇#PostConvo #IBDPoll 1️⃣
🟢In the True North open-label extension, the findings indicated that approx 1/2 the pts who failed to achieve a CR after 10wks of ozanimod induction tx benefitted from which of the following:
#PostConvo #IBDPoll 2️⃣ #MondayNightIBD
🏆🆓#CME👉🏼 http://bit.ly/3DZPnHV
Which class(es) of drugs have been shown to be as effective in patients with #UlcerativeColitis who were previously exposed to IFX than in patients who were bionaive?
#PostConvo #IBDPoll 1️⃣ #MondayNightIBD
🏆🆓#CME👉🏼 http://bit.ly/3DZPnHV
#ORAL Surveillance study: Risk of major adverse cardiovascular event (MACE) was ⬆️ with #Tofacitinib vs TNFi at median of 4 yrs f/up in pts> age 50 + at least 1 CV risk factors in which chronic disease:
Client Info
Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst